Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Feighner, JP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 33 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Feighner, JP; Ehrensing, RH; Kastin, AJ; Patel, A; Sverdlov, L; Hlavka, J; Abajian, HB; Noble, JF; Nicolau, G
      Double-blind, placebo-controlled study of INN 00835 (netamiftide) in the treatment of outpatients with major depression

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    2. Thase, ME; Feighner, JP; Lydiard, RB
      Citalopram treatment of fluoxetine nonresponders

      JOURNAL OF CLINICAL PSYCHIATRY
    3. Feighner, JP; Sverdlov, L; Nicolau, G; Noble, JF
      Cluster analysis of clinical data to identify subtypes within a study population following treatment with a new pentapeptide antidepressant

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    4. Feighner, JP; Ehrensing, RH; Kastin, AJ; Leonard, BE; Sverdlov, L; Nicolau, G; Patel, A; Hlavka, J; Abajian, H; Noble, JF
      A double-blind, placebo-controlled, efficacy, safety, and pharmacokinetic study of INN 00835, a novel antidepressant peptide, in the treatment of major depression

      JOURNAL OF AFFECTIVE DISORDERS
    5. Kelly, JP; Nicolau, G; Redmond, A; Leonard, BE; Noble, J; Sverdlov, L; Molinar, R; Kastin, AJ; Ehrensing, RH; Feighner, JP
      The effect of treatment with a new antidepressant, INN 00835, on platelet serotonin uptake in depressed patients

      JOURNAL OF AFFECTIVE DISORDERS
    6. Feighner, JP; Overo, K
      Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression

      JOURNAL OF CLINICAL PSYCHIATRY
    7. Feighner, JP
      Mechanism of action of antidepressant medications

      JOURNAL OF CLINICAL PSYCHIATRY
    8. Feighner, JP
      Overview of antidepressants currently used to treat anxiety disorders

      JOURNAL OF CLINICAL PSYCHIATRY
    9. FEIGHNER JP; ENTSUAH AR; MCPHERSON MK
      EFFICACY OF ONCE-DAILY VENLAFAXINE EXTENDED-RELEASE (XR) FOR SYMPTOMSOF ANXIETY IN DEPRESSED OUTPATIENTS

      Journal of affective disorders
    10. RUDOLPH RL; FABRE LF; FEIGHNER JP; RICKELS K; ENTSUAH R; DERIVAN AT
      A RANDOMIZED, PLACEBO-CONTROLLED, DOSE-RESPONSE TRIAL OF VENLAFAXINE HYDROCHLORIDE IN THE TREATMENT OF MAJOR DEPRESSION

      The Journal of clinical psychiatry
    11. ROGERS SL; FARLOW MR; DOODY RS; MOHS R; FRIEDHOFF LT; ALBALA B; BAUMEL B; BOOKER G; DEXTER J; FARMER M; FEIGHNER JP; FERRIS S; GORDON B; GORMAN DG; HANNA G; HARRELL LE; HUBBARD R; KENNEDY J; MCCARTHY J; SCHARRE DW; SCHAERF F; SCHNEIDER L; SELTZER B; SIEGAL A; STARK SR; STRAUSS A; WALSHE TM
      A 24-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DONEPEZIL IN PATIENTS WITH ALZHEIMERS-DISEASE

      Neurology
    12. Boyer, W; Feighner, JP
      The utility of SSRIs in anxious depression

      SSRIS IN DEPRESSION AND ANXIETY
    13. FEIGHNER JP; BENNETT ME; ROBERTS DL; DAMICO F; OBRIEN K
      A DOUBLE-BLIND TRIAL OF NEFAZODONE VERSUS PLACEBO IN DEPRESSED INPATIENTS

      Psychopharmacology bulletin
    14. FINKELSTEIN SN; BERNDT ER; GREENBERG PE; PARSLEY RA; RUSSELL JM; KELLER MB; GELENBERG A; DELGADO P; DEAN J; STEWARD J; BOLOGNA L; JOYCE P; CARMAN JS; FEIGHNER JP; MCNEAL C; HENDRICKSON G; FAWCETT J; ZAJECKA J; JEFFRIES H; RUSH AJ; TRAPP G; HOLDEN M; HIRSCHFELD RMA; RUSSELL J; TALBOT K; SCOTT R; KOCSIS JH; MARKOWITZ J; FRIEDMAN R; CAPPOLINO C; GNIEWESCH L; MILLER N; THASE ME; HOWLAND R; MCGREARY J; STUPAR L; HOGARTY S; KEITNER G; HOWARD D; CROOKS S; SHEA MT; PATO MT; COHEN S; TODDLINGLEY L; SCHATZBERG AF; KORAN L; JACOB M; COX K; BREEN JA; KLEIN DN; KLEIN L; HENN; SCHALGER; MCCULLOUGH JP; KORNSTEIN S; BURKE L
      IMPROVEMENT IN SUBJECTIVE WORK PERFORMANCE AFTER TREATMENT OF CHRONICDEPRESSION - SOME PRELIMINARY-RESULTS

      Psychopharmacology bulletin
    15. BENTKOVER JD; FEIGHNER JP
      COST-ANALYSIS OF PAROXETINE VERSUS IMIPRAMINE IN MAJOR DEPRESSION

      PharmacoEconomics
    16. ASCHER JA; COLE JO; COLIN JN; FEIGHNER JP; FERRIS RM; FIBIGER HC; GOLDEN RN; MARTIN P; POTTER WZ; RICHELSON E; SULSER F
      BUPROPION - A REVIEW OF ITS MECHANISM OF ANTIDEPRESSANT ACTIVITY

      The Journal of clinical psychiatry
    17. FEIGHNER JP
      CARDIOVASCULAR SAFETY IN DEPRESSED-PATIENTS - FOCUS ON VENLAFAXINE

      The Journal of clinical psychiatry
    18. FEIGHNER JP
      COMPLIANCE AND QUALITY OF RESPONSE ARE MAJOR CONTRIBUTORS TO COST-EFFECTIVE ANTIDEPRESSANT THERAPY

      Human psychopharmacology
    19. MONTGOMERY S; BEAUMONT G; FEIGHNER JP; FARMER R; HENRY J; LECRUBIER Y; DALY R; LEONARD B
      ANTIDEPRESSANT AND OVERDOSE TOXICITY - PANEL DISCUSSION

      Human psychopharmacology
    20. FEIGHNER JP
      CLINICAL EFFECTS OF SELECTIVE SEROTONIN R EUPTAKE INHIBITORS - A SURVEY

      Fortschritte der Neurologie, Psychiatrie
    21. NIERENBERG AA; FEIGHNER JP; RUDOLPH R; COLE JO; SULLIVAN J
      VENLAFAXINE FOR TREATMENT-RESISTANT UNIPOLAR DEPRESSION

      Journal of clinical psychopharmacology
    22. RICHELSON E; PRESKORN SH; FEIGHNER JP; CUNNINGHAM LA; ROOSE SP; KELLER MB
      ANTIDEPRESSANT DRUG SELECTION - CRITERIA AND OPTIONS - DISCUSSION

      The Journal of clinical psychiatry
    23. FEIGHNER JP; KELLER MB; PRESKORN SH; ROOSE SP; DREVETS WC
      THE NATURAL-HISTORY AND HETEROGENEITY OF DEPRESSIVE-DISORDERS - IMPLICATIONS FOR RATIONAL ANTIDEPRESSANT THERAPY - DISCUSSION

      The Journal of clinical psychiatry
    24. PRESKORN SH; RICHELSON E; ROOSE SP; FEIGHNER JP; CUNNINGHAM LA; DREVETS WC
      THE PHARMACOLOGY OF ANTIDEPRESSANTS AT THE SYNAPSE - FOCUS ON NEWER COMPOUNDS - DISCUSSION

      The Journal of clinical psychiatry
    25. FEIGHNER JP; BURKE MJ; PRESKORN SH; KELLER MB; DREVETS WC
      PHARMACOECONOMIC CONSIDERATIONS WHEN EVALUATING TREATMENT OPTIONS FORMAJOR DEPRESSION - DISCUSSION

      The Journal of clinical psychiatry
    26. ROOSE SP; NIERENBERG AA; PRESKORN SH; FEIGHNER JP; DREVETS WC
      THE TREATMENT OF SEVERE DEPRESSION - IS THERE AN EFFICACY GAP BETWEENSSRI AND TCA ANTIDEPRESSANT GENERATIONS - DISCUSSION

      The Journal of clinical psychiatry
    27. FEIGHNER JP
      THE ROLE OF VENLAFAXINE IN RATIONAL ANTIDEPRESSANT THERAPY

      The Journal of clinical psychiatry
    28. CUNNINGHAM LA; FEIGHNER JP; ROOSE SP; RICHELSON E; PRESKORN SH; DREVETS WC
      THE ROLE OF VENLAFAXINE IN RATIONAL ANTIDEPRESSANT THERAPY - DISCUSSION

      The Journal of clinical psychiatry
    29. FEIGHNER JP; ROOSE SP; PRESKORN SH
      ANTIDEPRESSANT CHOICE IN THE PATIENT WITH CARDIAC DISEASE - LESSONS FROM THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL (CAST) STUDIES - DISCUSSION

      The Journal of clinical psychiatry
    30. PRESKORN SH; FEIGHNER JP; CUNNINGHAM LA; ROOSE SP; BURKE MJ
      FACTORS TO CONSIDER IN SELECTING AN ANTIDEPRESSANT - CONCLUDING DISCUSSION

      The Journal of clinical psychiatry
    31. CLAGHORN JL; FEIGHNER JP
      A DOUBLE-BLIND COMPARISON OF PAROXETINE WITH IMIPRAMINE IN THE LONG-TERM TREATMENT OF DEPRESSION

      Journal of clinical psychopharmacology
    32. BOYER WF; FEIGHNER JP
      A PLACEBO-CONTROLLED DOUBLE-BLIND MULTICENTER TRIAL OF 2 DOSES OF IPSAPIRONE VERSUS DIAZEPAM IN GENERALIZED ANXIETY DISORDER

      International clinical psychopharmacology
    33. FEIGHNER JP; COHN JB; FABRE LF; FIEVE RR; MENDELS J; SHRIVASTAVA RK; DUNBAR GC
      A STUDY COMPARING PAROXETINE PLACEBO AND IMIPRAMINE IN DEPRESSED-PATIENTS

      Journal of affective disorders


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 11:54:46